Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease

Journal of Neuroscience

Volumn 30, Issue 3, 2010, Pages 1049-1056

  Tang, Chris C ^a   Poston, Kathleen L ^a,c   Dhawan, Vijay ^a,b   Eidelberg, David ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; LEVODOPA; SELEGILINE; DIAGNOSTIC AGENT; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; BODY SIZE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMISPHERE; HUMAN; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; STATISTICAL SIGNIFICANCE; AGED; ANALYSIS OF VARIANCE; BRAIN CIRCULATION; BRAIN MAPPING; COGNITIVE DEFECT; CORPUS STRIATUM; HEMISPHERIC DOMINANCE; LONGITUDINAL STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN BINDING; SCINTISCANNING; STATISTICS; TIME;

AGED; ANALYSIS OF VARIANCE; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FLUORODEOXYGLUCOSE F18; FUNCTIONAL LATERALITY; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; STATISTICS AS TOPIC; TIME FACTORS;

EID: 75749128636     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4188-09.2010     Document Type: Article

References (28)

1. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D (2006) Network modulation in the treatment of Parkinson's disease. Brain 129:2667-2678.
2. Bezard E, Gross CE, Brotchie JM (2003) Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 26:215-221.
3. Buhmann C, Binkofski F, Klein C, Büchel C, van Eimeren T, Erdmann C, Hedrich K, Kasten M, Hagenah J, Deuschl G, Pramstaller PP, Siebner HR (2005) Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain 128:2281-2290.
4. Carbon M, Eidelberg D (2009) Abnormal structure-function relationships in hereditary dystonia. Neuroscience 164:220 -229.
5. Dhawan V, Eidelberg D (2006) PET imaging in Parkinson's disease and other neurodegenerative disorders. In: The neurobiology of disease (Gilman S, ed), pp 821-828. San Diego: Academic.
6. Eckert T, Tang C, Eidelberg D (2007) Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 6:926 -932.
7. Eidelberg D (2009) Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci 32:548 -557.
8. Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A (1997) Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120:1315-1324.
9. Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, During MJ, Eidelberg D (2007a) Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A 104:19559 -19564.
10. Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, Paulsen JS, Dhawan V, Eidelberg D (2007b) Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain 130:2858 -2867.
11. Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, SchillaciO (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Nuc Med Comm 26:421- 426.
12. Hirano S, Asanuma K, Ma Y, Tang C, Feigin A, Dhawan V, Carbon M, Eidelberg D (2008) Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 28:4201- 4209.
13. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson's disease. Brain 130:1834 -1846.
14. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D (2008) Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70:1470 -1477.
15. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
16. Lin TP, Carbon M, Tang C, Mogilner AY, Sterio D, Beric A, Dhawan V, Eidelberg D (2008) Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain 131:1373-1380.
17. Little R, Rubin DB, eds (2002) Statistical analysis with missing data, Ed 2. New York: Wiley.
18. Ma Y, Dhawan V, Mentis M, Chaly T, Spetsieris PG, Eidelberg D (2002) Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study. Synapse 45:125-133.
19. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007) Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 27:597- 605.
20. Ma Y, Tang C, Moeller JR, Eidelberg D (2009) Abnormal regional brain function in Parkinson's disease: truth or fiction? Neuroimage 45: 260 -266.
21. Moeller JR, Eidelberg D (1997) Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. Brain 120:2197-2206.
22. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ (2007) Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104:19067-19072.
23. Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Brücke T (2003) Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT. Mov Disord 18:1266 -1272.
24. Pourfar M, Feigin A, Eidelberg D (2007) Natural history. In: Parkinson's disease: diagnosis and clinical management, Ed 2 (Factor S, Weiner W, eds), pp 127-133. New York: Demos Medical Publishing.
25. Spetsieris P, Ma Y, Dhawan V, Moeller J, Eidelberg D (2006) Highly automated computer-aided diagnosis of neurological disorders using functional imaging. Proc SPIE 6144:61445M1-12.
26. Spetsieris PG, Ma Y, Dhawan V, Eidelberg D (2009) Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 45:1241-1252.
27. Tang C, Eckert T, Dhawan V, Eidelberg D (2008) Parkinson's disease: evidence for a short metabolic preclinical period. Neurology 70:A436.
28. Wichmann T, DelongMR (2007) Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders. Handb Clin Neurol 83:1-18.